EAM Investors’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
2017
Q1
$735K Buy
2016
Q4
Sell
2016
Q3
$917K Buy
2015
Q4
Sell
2015
Q3
$2.53M Sell
2015
Q2
$5.01M Buy
2015
Q1
$3.09M Sell
2014
Q4
$4.18M Buy